Biochemistry
-
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
This article has 4 authors:Reviewed by ScreenIT
-
Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols towards Downstream Isolation and Analysis
This article has 12 authors:Reviewed by ScreenIT
-
In vitro measurements of protein–protein interactions show that antibody affinity governs the inhibition of SARS-CoV-2 spike/ACE2 binding in convalescent serum
This article has 12 authors:Reviewed by ScreenIT
-
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex
This article has 57 authors:Reviewed by ScreenIT
-
Protonation states in SARS-CoV-2 main protease mapped by neutron crystallography
This article has 8 authors:Reviewed by ScreenIT
-
The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro
This article has 7 authors:Reviewed by ScreenIT
-
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
This article has 10 authors:Reviewed by ScreenIT
-
Conformational diversity of CDR region during affinity maturation determines the affinity and stability of Sars-Cov-1 VHH-72 nanobody
This article has 1 author:Reviewed by ScreenIT
-
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
This article has 4 authors:Reviewed by ScreenIT
-
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
This article has 4 authors:Reviewed by ScreenIT